SCOPE's Clinical Trial Tech: Venture, Innovation, & Partnering Conference
SCOPEの治験テック：ベンチャー・イノベーション・提携カンファレンス
2023年2月7日 すべて東部標準時
2月6日（月）
SCOPE’s 2nd Annual Masters of Clinical Research Golf Tournament
Connect with your peers and colleagues at SCOPE's 2nd Annual Masters of Clinical Research Golf Tournament.
SCOPE's Kick-Off Happy Hour
2月7日（火）
Registration Open
Networking Breakfast
What Are the Most Exciting Areas for Investment When It Comes to the Future of Clinical Trials: Perspectives from Different Investors
Eric M. Snyder, Partner, Novo Ventures (US), Inc.
Where are investors putting their investment and what are the exciting technologies? How are we dealing with Valuations in today’s market? What are the main themes that each investor is following? Which of the technologies are priority for each investor type (technologies in patient recruitment, decentralized, automation, digital twin, digital biomarkers)? For strategics, how do they approach partnering with investors?
What’s the ROI for Clinical Trial Innovation Investing for Different Types of Investors?
Konstantina Katcheves, Senior Vice President, Business Development, Bristol Myers Squibb Co.
This panel will share perspectives from strategic investors, VCs, and more as they explore the value that new clinical trial approaches, including DCT, bring to the broader ecosystem. Can these innovative companies support existing valuations? What is the motivation of the different investors in the space?
Networking Coffee Break
Bridging the Chasm of Research and Care: How Is the Landscape Evolving for Investors and Start-Ups?
Jared Saul, Global Head, Healthcare + Life Sciences, Amazon Web Services LLC
We’ve all seen the news of Amazon + OneMedical, and CVS and Signify. What do the investments in care mean for research? And as the ecosystem evolves to a more integrated tech-enabled approach to care and research, what does that mean for start-ups and investors moving forward. This panel will also cover how technology, including platforms, wearables, homecare, monitoring etc., is enabling this integration, automations, and better inclusion. Can tech finally help us bridge the gap between research and care and move to an integrated, seamless approach?
How Are CEOs and Founding Teams of Innovative Companies in the Clinical Trial Space Overcoming Hurdles to Fundraising, Pilots, and Scaling?
What has it been like fundraising at this time? What is it like to be a CEO at this time? What was your last raise like? What experience do you want to share about working with your investors? What has it been like to raise capital in this market crash?
Networking Luncheon
Are We Getting Closer to the Holy Grail of Data Quality?
George Mathew, Chief Medical Officer, North America, Dedalus
This panel will explore investments and innovation into the data space, including interoperability, synthetic control arms, digital biomarkers, and the regulator perspective and why data quality is the holy grail of our industry.
Networking Coffee Break
Can We Shorten the Long Arc of Investing in the Clinical Trial Space?
Evan Norton, Founder & Managing Partner, SPRIG Equity
How do We Scale Companies? This panel will explore the timelines of company growth and scale in the complex clinical trial space. Companies need to scale to be relevant enough to IPO, what is the growth trajectory for any given company?
How Are CEOs and Founding Teams of Innovative Companies in the Clinical Trial Space Overcoming Hurdles to Fundraising, Pilots, and Scaling?
Thorsten Wirkes, Senior Vice President, Bertelsmann Next, Bertelsmann Investments
What has it been like fundraising at this time? What is it like to be a CEO at this time? What was your last raise like? What experience do you want to share about working with your investors? What has it been like to raise capital in this market crash?
Networking Reception
Close of Summit
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。
